Rated 9.8 out of 10 in severity, the flaw could allow a remote attacker to gain unauthorized access to applications.

Some stories, though, were more impactful or popular with our readers than others. This article explores 15 of the biggest ...

Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...